Literature DB >> 3546379

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.

R N Bergman, R Prager, A Volund, J M Olefsky.   

Abstract

Studies were done to determine whether the minimal model approach and the glucose clamp measure equivalent indices of insulin action. Euglycemic glucose clamps (glucose, G: 85 mg/dl) were performed at two rates of insulin (I) infusion (15 and 40 mU/min per m2) in 10 subjects (body mass index, BMI, from 21 to 41 kg/m2). Insulin sensitivity index (SI) from clamps varied from 0.15 to 3.15 (mean: 1.87 +/- 0.36 X 10(-2) dl/[min per m2] per microU/ml), and declined linearly with increasing adiposity (versus BMI: r = -0.97; P less than 0.001). SI from modeling the modified frequently sampled intravenous tolerance test varied from 0.66 to 7.34 X 10(-4) min-1 per microU/ml, and was strongly correlated with SIP(clamp) (r = 0.89; P less than 0.001). SI and SIP(clamp) were similar (0.046 +/- 0.008 vs. 0.037 +/- 0.007 dl/min per microU/ml, P greater than 0.35); the relation had a slope not different from unity (1.05 P greater than 0.70) and passed through the origin (P greater than 0.40). However, on a period basis, SI exceeded SIP(clamp) slightly, due to inhibition of hepatic glucose output during the FSIGT, not included in SIP(clamp). These methods are equivalent for assessment of overall insulin sensitivity in normal and insulin-resistant nondiabetic subjects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546379      PMCID: PMC424201          DOI: 10.1172/JCI112886

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Glucose intolerance and aging: evidence for tissue insensitivity to insulin.

Authors:  R A Defronzo
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

2.  In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man.

Authors:  R S Gray; J A Scarlett; J Griffin; J M Olefsky; O G Kolterman
Journal:  Diabetes       Date:  1982-10       Impact factor: 9.461

3.  Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes.

Authors:  D T Finegood; R N Bergman
Journal:  Am J Physiol       Date:  1983-05

4.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

Authors:  R N Bergman; L S Phillips; C Cobelli
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

5.  Experimental validation of measurements of glucose turnover in nonsteady state.

Authors:  J Radziuk; K H Norwich; M Vranic
Journal:  Am J Physiol       Date:  1978-01

6.  Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.

Authors:  R S Bar; W R Levis; M M Rechler; L C Harrison; C Siebert; J Podskalny; J Roth; M Muggeo
Journal:  N Engl J Med       Date:  1978-05-25       Impact factor: 91.245

7.  Quantitative estimation of insulin sensitivity.

Authors:  R N Bergman; Y Z Ider; C R Bowden; C Cobelli
Journal:  Am J Physiol       Date:  1979-06

8.  Glucose storage deficiency as a cause of insulin resistance in obese-hyperinsulinaemic diabetes.

Authors:  J P Felber; E Jéquier
Journal:  Int J Obes       Date:  1982

9.  Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance.

Authors:  G M Reaven; J Moore; M Greenfield
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

10.  Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

Authors:  O G Kolterman; J Insel; M Saekow; J M Olefsky
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  141 in total

1.  Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males.

Authors:  Daniel J Lesser; Rajeev Bhatia; Winston H Tran; Flavia Oliveira; Ricardo Ortega; Thomas G Keens; Steven D Mittelman; Michael C K Khoo; Sally L Davidson Ward
Journal:  Pediatr Res       Date:  2012-06-05       Impact factor: 3.756

Review 2.  Obesity, insulin resistance, and pregnancy outcome.

Authors:  Patrick M Catalano
Journal:  Reproduction       Date:  2010-05-10       Impact factor: 3.906

3.  An inadequate glycaemic response to glucagon is linked to insulin resistance in preterm infants?

Authors:  L Jackson; A Burchell; A McGeechan; R Hume
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

Review 4.  Comparison of equivalence and determination of diagnostic utility of min-mod and clamp methods for insulin resistance in diabetes free subjects: a meta-analysis.

Authors:  Antonio Gordillo-Moscoso; J Francisco Valadéz-Castillo; Peter B Mandeville; J Francisco Hernández-Sierra
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

5.  Minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in type 1 (insulin-dependent) diabetic pancreas allograft recipients.

Authors:  K Osei; D A Cottrell; M L Henry; R J Tesi; R M Ferguson; T M O'Dorisio
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

6.  Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia.

Authors:  Marcia R Batista; Marta S Smith; Wanda L Snead; Cynthia C Connolly; D Brooks Lacy; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

7.  Shock wave lithotripsy targeting of the kidney and pancreas does not increase the severity of metabolic syndrome in a porcine model.

Authors:  Rajash K Handa; Andrew P Evan; Bret A Connors; Cynthia D Johnson; Ziyue Liu; Mouhamad Alloosh; Michael Sturek; Carmella Evans-Molina; Jessica A Mandeville; Ehud Gnessin; James E Lingeman
Journal:  J Urol       Date:  2014-03-18       Impact factor: 7.450

8.  Increased plasma norepinephrine levels in previously pre-eclamptic women.

Authors:  K H Lampinen; M Rönnback; P-H Groop; M G Nicholls; T G Yandle; R J Kaaja
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

9.  Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

Review 10.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.